Treatment with low-dose cytosine arabinoside followed by administration of macrophage colony-stimulating factor prolongs the survival of patients with RAEB, RAEB-T, or leukemic phase myelodysplastic syndrome: a pilot study.

International journal of hematology

Volumn 71, Issue 4, 2000, Pages 366-371

  Fukuhara, T ^a   Miyake, T ^a   Maekawa, I ^a   Kurosawa, M ^a   Suzuki, S ^a   Noto, S ^a   Mori, A ^a   Chiba, K ^a   Toyoshima, T ^a   Hirano, T ^a   Morioka, M ^a   Tsutsumi, Y ^a   Okabe, M ^a   Kakinoki, Y ^a  

^a Asahikawa City Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTARABINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; MYELODYSPLASTIC SYNDROME; PILOT STUDY; REFRACTORY ANEMIA WITH EXCESS BLASTS; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; CYTARABINE; FEMALE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PILOT PROJECTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0034204377     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)